La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes

Identifieur interne : 002177 ( Istex/Corpus ); précédent : 002176; suivant : 002178

Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes

Auteurs : Katherine J. Castor ; Johanna Mancini ; Johanna Fakhoury ; Johanna Weill ; Johanna Kieltyka ; Johanna Englebienne ; Nicole Avakyan ; Nicole Mittermaier ; Nicole Autexier ; Nicole Moitessier ; Nicole Sleiman

Source :

RBID : ISTEX:0EF6AF011A4A4F5E982B830E10D42935F4A36FEB

Abstract

A rationally designed progression of phenanthroimidazole platinum(II) complexes were examined for their ability to target telomere‐derived intramolecular G‐quadruplex DNA. Through the use of circular dichroism, fluorescence displacement assays, and molecular modeling we show that these complexes template and stabilize G‐quadruplexes from sequences based on the human telomeric repeat (TTAGGG)n. The greatest stabilization was observed for the p‐chlorophenyl derivative 6 (G4DC50=0.31 μM). We also show that the G‐quadruplex binding complexes are able to inhibit telomerase activity through a modified telomerase repeat amplification protocol (TRAP‐LIG assay). Preliminary cell studies show that complex 6 is preferentially cytotoxic toward cancer over normal cell lines, indicating its potential use in cancer therapy.

Url:
DOI: 10.1002/cmdc.201100453

Links to Exploration step

ISTEX:0EF6AF011A4A4F5E982B830E10D42935F4A36FEB

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="no">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes</title>
<author>
<name sortKey="Castor, Katherine J" sort="Castor, Katherine J" uniqKey="Castor K" first="Katherine J." last="Castor">Katherine J. Castor</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mancini, Johanna" sort="Mancini, Johanna" uniqKey="Mancini J" first="Johanna" last="Mancini">Johanna Mancini</name>
<affiliation>
<mods:affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fakhoury, Johanna" sort="Fakhoury, Johanna" uniqKey="Fakhoury J" first="Johanna" last="Fakhoury">Johanna Fakhoury</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Weill, Johanna" sort="Weill, Johanna" uniqKey="Weill J" first="Johanna" last="Weill">Johanna Weill</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kieltyka, Johanna" sort="Kieltyka, Johanna" uniqKey="Kieltyka J" first="Johanna" last="Kieltyka">Johanna Kieltyka</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Englebienne, Johanna" sort="Englebienne, Johanna" uniqKey="Englebienne J" first="Johanna" last="Englebienne">Johanna Englebienne</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Avakyan, Nicole" sort="Avakyan, Nicole" uniqKey="Avakyan N" first="Nicole" last="Avakyan">Nicole Avakyan</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mittermaier, Nicole" sort="Mittermaier, Nicole" uniqKey="Mittermaier N" first="Nicole" last="Mittermaier">Nicole Mittermaier</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Autexier, Nicole" sort="Autexier, Nicole" uniqKey="Autexier N" first="Nicole" last="Autexier">Nicole Autexier</name>
<affiliation>
<mods:affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moitessier, Nicole" sort="Moitessier, Nicole" uniqKey="Moitessier N" first="Nicole" last="Moitessier">Nicole Moitessier</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sleiman, Nicole" sort="Sleiman, Nicole" uniqKey="Sleiman N" first="Nicole" last="Sleiman">Nicole Sleiman</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0EF6AF011A4A4F5E982B830E10D42935F4A36FEB</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/cmdc.201100453</idno>
<idno type="url">https://api-v5.istex.fr/document/0EF6AF011A4A4F5E982B830E10D42935F4A36FEB/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002177</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002177</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<author>
<name sortKey="Castor, Katherine J" sort="Castor, Katherine J" uniqKey="Castor K" first="Katherine J." last="Castor">Katherine J. Castor</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mancini, Johanna" sort="Mancini, Johanna" uniqKey="Mancini J" first="Johanna" last="Mancini">Johanna Mancini</name>
<affiliation>
<mods:affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fakhoury, Johanna" sort="Fakhoury, Johanna" uniqKey="Fakhoury J" first="Johanna" last="Fakhoury">Johanna Fakhoury</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Weill, Johanna" sort="Weill, Johanna" uniqKey="Weill J" first="Johanna" last="Weill">Johanna Weill</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kieltyka, Johanna" sort="Kieltyka, Johanna" uniqKey="Kieltyka J" first="Johanna" last="Kieltyka">Johanna Kieltyka</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Englebienne, Johanna" sort="Englebienne, Johanna" uniqKey="Englebienne J" first="Johanna" last="Englebienne">Johanna Englebienne</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Avakyan, Nicole" sort="Avakyan, Nicole" uniqKey="Avakyan N" first="Nicole" last="Avakyan">Nicole Avakyan</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mittermaier, Nicole" sort="Mittermaier, Nicole" uniqKey="Mittermaier N" first="Nicole" last="Mittermaier">Nicole Mittermaier</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Autexier, Nicole" sort="Autexier, Nicole" uniqKey="Autexier N" first="Nicole" last="Autexier">Nicole Autexier</name>
<affiliation>
<mods:affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moitessier, Nicole" sort="Moitessier, Nicole" uniqKey="Moitessier N" first="Nicole" last="Moitessier">Nicole Moitessier</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sleiman, Nicole" sort="Sleiman, Nicole" uniqKey="Sleiman N" first="Nicole" last="Sleiman">Nicole Sleiman</name>
<affiliation>
<mods:affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</mods:affiliation>
</affiliation>
</author>
</analytic>
<series>
<idno type="ISSN">1860-7179</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1860-7179</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">A rationally designed progression of phenanthroimidazole platinum(II) complexes were examined for their ability to target telomere‐derived intramolecular G‐quadruplex DNA. Through the use of circular dichroism, fluorescence displacement assays, and molecular modeling we show that these complexes template and stabilize G‐quadruplexes from sequences based on the human telomeric repeat (TTAGGG)n. The greatest stabilization was observed for the p‐chlorophenyl derivative 6 (G4DC50=0.31 μM). We also show that the G‐quadruplex binding complexes are able to inhibit telomerase activity through a modified telomerase repeat amplification protocol (TRAP‐LIG assay). Preliminary cell studies show that complex 6 is preferentially cytotoxic toward cancer over normal cell lines, indicating its potential use in cancer therapy.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Katherine J. Castor</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Johanna Mancini</name>
<affiliations>
<json:string>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dr. Fakhoury</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dr. Weill</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dr. Kieltyka</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dr. Englebienne</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nicole Avakyan</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Prof. Mittermaier</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Prof. Autexier</name>
<affiliations>
<json:string>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</json:string>
<json:string>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Prof. Moitessier</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
<json:string>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
<json:item>
<name>Prof. Sleiman</name>
<affiliations>
<json:string>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
<json:string>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>antitumor agents</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>G‐quadruplexes</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>human telomeres</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>phenanthroimidazole</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>platinum</value>
</json:item>
</subject>
<articleId>
<json:string>CMDC201100453</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<qualityIndicators>
<score>6.272</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595.276 x 841.89 pts (A4)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>820</abstractCharCount>
<pdfWordCount>8002</pdfWordCount>
<pdfCharCount>47062</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>106</abstractWordCount>
</qualityIndicators>
<title>Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>ChemMedChem</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1002/(ISSN)1860-7187</json:string>
</doi>
<issn>
<json:string>1860-7179</json:string>
</issn>
<eissn>
<json:string>1860-7187</json:string>
</eissn>
<publisherId>
<json:string>CMDC</json:string>
</publisherId>
<volume>7</volume>
<issue>1</issue>
<pages>
<first>85</first>
<last>94</last>
<total>10</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Full Paper</value>
</json:item>
</subject>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>pharmacology & pharmacy</json:string>
<json:string>chemistry, medicinal</json:string>
</wos>
<scienceMetrix>
<json:string>natural sciences</json:string>
<json:string>chemistry</json:string>
<json:string>medicinal & biomolecular chemistry</json:string>
</scienceMetrix>
</categories>
<publicationDate>2012</publicationDate>
<copyrightDate>2012</copyrightDate>
<doi>
<json:string>10.1002/cmdc.201100453</json:string>
</doi>
<id>0EF6AF011A4A4F5E982B830E10D42935F4A36FEB</id>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api-v5.istex.fr/document/0EF6AF011A4A4F5E982B830E10D42935F4A36FEB/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api-v5.istex.fr/document/0EF6AF011A4A4F5E982B830E10D42935F4A36FEB/fulltext/zip</uri>
</json:item>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api-v5.istex.fr/document/0EF6AF011A4A4F5E982B830E10D42935F4A36FEB/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<mods version="3.6">
<titleInfo lang="en">
<title>Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes</title>
</titleInfo>
<name type="personal">
<namePart type="given">Katherine J.</namePart>
<namePart type="family">Castor</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Johanna</namePart>
<namePart type="family">Mancini</namePart>
<affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Fakhoury</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Weill</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Kieltyka</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Englebienne</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nicole</namePart>
<namePart type="family">Avakyan</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Prof.</namePart>
<namePart type="family">Mittermaier</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Prof.</namePart>
<namePart type="family">Autexier</namePart>
<affiliation>Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)</affiliation>
<affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Prof.</namePart>
<namePart type="family">Moitessier</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="termsOfAddress">Prof.</namePart>
<namePart type="family">Sleiman</namePart>
<affiliation>Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<affiliation>Chantal Autexier, Departments of Anatomy and Cell Biology and Experimental Medicine, McGill University, Lady Davis Institute of Medical Research, 3755 Côte Ste‐Catherine Road, Montreal, QC, H3T 1E2 (Canada)Nicolas Moitessier, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797Hanadi F. Sleiman, Department of Chemistry, McGill University, 801 Sherbrooke West, Montreal, QC, H3A 2K6 (Canada), Fax: (+1) 514‐398‐3797</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>WILEY‐VCH Verlag</publisher>
<place>
<placeTerm type="text">Weinheim</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2012-01-02</dateIssued>
<dateCaptured encoding="w3cdtf">2011-09-29</dateCaptured>
<copyrightDate encoding="w3cdtf">2012</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">8</extent>
<extent unit="tables">1</extent>
<extent unit="references">45</extent>
</physicalDescription>
<abstract>A rationally designed progression of phenanthroimidazole platinum(II) complexes were examined for their ability to target telomere‐derived intramolecular G‐quadruplex DNA. Through the use of circular dichroism, fluorescence displacement assays, and molecular modeling we show that these complexes template and stabilize G‐quadruplexes from sequences based on the human telomeric repeat (TTAGGG)n. The greatest stabilization was observed for the p‐chlorophenyl derivative 6 (G4DC50=0.31 μM). We also show that the G‐quadruplex binding complexes are able to inhibit telomerase activity through a modified telomerase repeat amplification protocol (TRAP‐LIG assay). Preliminary cell studies show that complex 6 is preferentially cytotoxic toward cancer over normal cell lines, indicating its potential use in cancer therapy.</abstract>
<abstract>A rational progression of π‐extended phenanthroimidazole PtII complexes were synthesized. Their interactions with and relative binding affinities for human telomere‐derived quadruplex DNA were studied by CD, FID assays, molecular modeling, and a TRAP assay. Significant binding affinity and selectivity for quadruplex DNA over duplex DNA was observed; this led to promising preliminary cytotoxicity studies for [(CLIP)Pt(en)] in cancer cells.</abstract>
<note type="funding">Canadian Institute for Health Research (CIHR) - No. MOP‐89978; </note>
<subject lang="en">
<genre>keywords</genre>
<topic>antitumor agents</topic>
<topic>G‐quadruplexes</topic>
<topic>human telomeres</topic>
<topic>phenanthroimidazole</topic>
<topic>platinum</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>ChemMedChem</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>ChemMedChem</title>
</titleInfo>
<genre type="journal">journal</genre>
<note type="content"> Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer‐reviewed, but not copy‐edited or typeset. They are made available as submitted by the authors.Supporting Info Item: miscellaneous_information - </note>
<subject>
<genre>article-category</genre>
<topic>Full Paper</topic>
</subject>
<identifier type="ISSN">1860-7179</identifier>
<identifier type="eISSN">1860-7187</identifier>
<identifier type="DOI">10.1002/(ISSN)1860-7187</identifier>
<identifier type="PublisherID">CMDC</identifier>
<part>
<date>2012</date>
<detail type="volume">
<caption>vol.</caption>
<number>7</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>85</start>
<end>94</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">0EF6AF011A4A4F5E982B830E10D42935F4A36FEB</identifier>
<identifier type="DOI">10.1002/cmdc.201100453</identifier>
<identifier type="ArticleID">CMDC201100453</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2012 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>WILEY‐VCH Verlag</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002177 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002177 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:0EF6AF011A4A4F5E982B830E10D42935F4A36FEB
   |texte=   Platinum(II) Phenanthroimidazoles for Targeting Telomeric G‐Quadruplexes
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022